expenses of Baht 5.49 million and 8 .20 million, respectively. The proporation of selling expenses incurred compared to total revenues were 2.0% and 3.0% repectively. The increase thereof resulted primarily
the 2nd quarterof Year 2018 and 2019 were in amounts of Baht 135.14 million and Baht 168.99 million, respectively, which increased by 25.1% compared to the total revenue. The increasing in revenue Baht
, respectively. Apart from launching new products, our product strategies also include the shaping up additional revenue stream from distribution of diversified set of 3rd party products in both food and non-food
gross profits from overseas sales amounted to THB 1,198 million and THB 816 million respectively, referring to gross profit margins of 32.2% and 33.0%, correspondingly. Such reduction in gross profit
and 6-month periods ending 30 June 2017, respectively. Apart from launching new products, our product strategies also include the shaping up additional revenue stream from distribution of diversified
-month period ended September 30, 2017 and the nine-month period ended September 30, 2018, respectively. The figures represent a period-on-period increase of 20.55% due mainly to an activating new hospital
nine-month period ended September 30, 2018 and the nine-month period ended September 30, 2019, respectively. The figures represent a period-on-period increase of 65.46% due mainly to an increasing in
operating performance of the Company for the year ended 31 December 2017 are as follows : Statement of Income Total Revenue The company earned THB 941.7 MB and 909.9 MB in year 2016 and 2017 respectively, A
nine-month period ended September 30, 2019 and the nine-month period ended September 30, 2020, respectively. The figures represent a period-on-period decrease of 6.37% due mainly to the Corona Viruses
million, respectively, resulting in an overall growth rate 13.7%. The revenues from in-patients were Baht 305.36 million and 363.19 million respectively, which increased by 18.9%. The revenues from out